Trulicity Cost: List Price, Insurance, and What You Pay

This PlexusDx Education Hub article breaks down what Trulicity actually costs and how insurance, prior authorization, and compounding pathways reshape the number a patient pays. All figures are as of April 2026 and reported as published. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Eli Lilly or the Trulicity brand and does not sell, distribute, or prescribe dulaglutide; the analysis below is educational.

Trulicity cost is one of the most-searched questions in the GLP-1 receptor agonist landscape as of April 2026, and the honest answer is "it depends." Out-of-pocket cost turns on insurance coverage, the indication written on the prescription, savings-card eligibility, pharmacy pricing, and whether a compounded alternative applies. This article walks the list price down to what people actually pay.

Trulicity's list price starting point

Trulicity list price is approximately $1,064 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). That number is the ceiling, not the norm — it precedes insurance, rebates, manufacturer savings cards, and pharmacy negotiation. What a patient pays depends on the plan, the formulary, prior authorization, and the indication on the prescription.

How insurance and prior authorization reshape the number

Commercial coverage depends on whether the prescription is written for an FDA-approved indication and on the plan's formulary and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; coverage for chronic weight management is more variable, often subject to BMI-based prior authorization, and some plans exclude weight-management indications entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products.

The manufacturer savings card and its exclusions

Eli Lilly publishes a manufacturer savings card that can substantially lower monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the card carries monthly and annual caps. Because eligibility and amounts change, verify the current terms on the manufacturer website at the time of fill. GoodRx and SingleCare publish separate cash-coupon prices that vary by pharmacy.

Compounding pathways after the 2024–2025 shortage resolution

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of those molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified; they are not identical to brand products and are priced separately.

Realistic out-of-pocket scenarios

With commercial insurance that covers the indication and the savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. With commercial insurance that does not cover the indication, cash-pay cost is closer to list price minus whatever coupon applies. Without insurance, cash-pay approaches list price; compounded alternatives through the PlexusDx Weight Management Protocols carry a separate pricing structure published on each product page.

PlexusDx does not sell, distribute, or prescribe Trulicity, but it does offer semaglutide and tirzepatide through its Weight Management Protocols. Whichever GLP-1 pathway compound you and your provider discuss, the underlying genetic architecture is the same. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, and MC4R variants that shape baseline GLP-1, appetite-regulation, and energy-balance biology. Knowing that profile before committing is the test before you invest approach.

Related PlexusDx reading: Trulicity Dosing, Trulicity Side Effects, Trulicity for Weight Loss, and Trulicity savings options.

Disclaimer: This article is educational. PlexusDx does not sell, prescribe, or recommend dulaglutide, liraglutide, retatrutide, cagrilintide, or any other therapeutic peptide in this category beyond the semaglutide and tirzepatide products in its Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start upstream with the genetic context. Take the Precision Peptide Genetic Test to understand the pathway biology that applies across every GLP-1 decision, or explore the Weight Management Protocols.

Frequently Asked Questions

How much does Trulicity cost per month?

Trulicity list price is approximately $1,064 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). Insurance, savings cards, and pharmacy pricing can substantially change what a patient pays at the counter. Verify the current price with the pharmacy before the fill.

Does insurance cover Trulicity?

It depends on the plan, formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; chronic weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there savings cards for Trulicity?

Eli Lilly publishes a manufacturer savings card for commercially-insured patients who meet eligibility criteria, and platforms like GoodRx publish separate discount prices. Government-insurance patients are typically excluded from the manufacturer card. Check the manufacturer site at the time of fill for current terms and caps.

Are there lower-cost alternatives to Trulicity?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide formulations at price points separate from the FDA-approved brand products. Compounded products are legally and factually different — not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, with pricing published on each product page.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education